The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world persistence and adherence with oral trifluridine/tipiracil or regorafenib in patients with colorectal cancer.
 
Fadi S. Braiteh
Honoraria - Amgen; ARIAD; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Daiichi Sankyo/Lilly; Genentech/Roche; Gilead Sciences; Guardant Health; Immunomedics; Incyte; Ipsen; Lexicon; Lilly; Puma Biotechnology; Regeneron; Sanofi/Aventis; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Coherus Biosciences; Daiichi Sankyo/Lilly; Deciphera; Eisai; Exelixis; Genentech/Roche; Guardant Health; Immunomedics; Incyte; Ipsen; Lilly; Merck; Merck; Merck; Pfizer; Regeneron; Sanofi; Taiho Oncology; Taiho Oncology; Takeda
Speakers' Bureau - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Genentech/Roche; Incyte; Insys Therapeutics; Ipsen; Lilly; Merck; Merck; Merrimack; Pfizer; Taiho Pharmaceutical
Travel, Accommodations, Expenses - Amgen; AstraZeneca/MedImmune; Bayer; Bayer/Onyx; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Clovis Oncology; Exelixis; HERON; Incyte; Insys Therapeutics; Ipsen; Lexicon; Merrimack; Novartis; Pfizer; Regeneron; Roche/Genentech; Sanofi; Taiho Pharmaceutical; Tesaro
 
Cynthia J. Girman
Employment - CERobs Consulting
Stock and Other Ownership Interests - Abbott; Abbvie; Becton Dickinson; Bristol-Myers Squibb; CureVac; CVS; IQVIA; Johnson & Johnson; LabCorp; Medtronic; Merck; Pfizer; Walgreens; Welltower
Speakers' Bureau - Dynamic Global Events, RWE and Market Access Symposium speaker
Research Funding - Taiho Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Elsevier Sciences as coeditor of textbook on pragmatic randomized trials
 
Jessica C. Young
Consulting or Advisory Role - CERobs Consulting
Research Funding - Taiho Oncology (Inst)
 
Mark D. Danese
Research Funding - Alexion Pharmaceuticals (Inst); Amgen (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Greenwich Biosciences (Inst); Mirati Therapeutics (Inst); Seagen (Inst); Taiho Oncology (Inst); Veracyte (Inst)
 
Debra E. Irwin
Employment - Aetion; IBM
Stock and Other Ownership Interests - IBM; UnitedHealthcare
Research Funding - IBM and Aetion receive funding for execution of research projects from multiple companies (Inst)
 
Reza Kazerooni
Employment - Taiho Oncology
 
Tehseen Salimi
Employment - Taiho Oncology
 
Robert Morlock
Stock and Other Ownership Interests - Abbvie; Artelo Biosciences; Regeneron; Takeda
Consulting or Advisory Role - Allergan (I); Evofem; HERON; Horizon Therapeutics; Ironwood Pharmaceuticals (I); Johnson & Johnson; Pfizer; Taiho Oncology
Patents, Royalties, Other Intellectual Property - Placebo Response Identification Tool
Travel, Accommodations, Expenses - Taiho Oncology
 
Robert S. Epstein
Employment - Epstein Health
Leadership - Decipher Biosciences; Fate Therapeutics; Illumina; Proteus Digital Health; Veracyte
Stock and Other Ownership Interests - Cigna; Decipher Biosciences; Fate Therapeutics; HealthRhythms; Illumina; Medocity; Merck; Proteus Digital Health; TriAxia Health; Veracyte
Consulting or Advisory Role - G1 Therapeutics; Halozyme; Janssen; Merck; Radius Health; Taiho Oncology
Research Funding - G1 Therapeutics; Radius Health; Taiho Oncology
Travel, Accommodations, Expenses - Pfizer